1. As of noon trading, Las Vegas Sands ( LVS) is up $0.54 (0.93) to $59.18 on light volume Thus far, 1.9 million shares of Las Vegas Sands exchanged hands as compared to its average daily volume of 5.8 million shares. The stock has ranged in price between $58.59-$59.26 after having opened the day at $58.71 as compared to the previous trading day's close of $58.64.

Las Vegas Sands Corp. develops, owns, and operates integrated resorts in Asia and the United States. Las Vegas Sands has a market cap of $47.8 billion and is part of the leisure industry. The company has a P/E ratio of 30.0, above the S&P 500 P/E ratio of 17.7. Shares are up 27.0% year to date as of the close of trading on Friday. Currently there are 16 analysts that rate Las Vegas Sands a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Las Vegas Sands as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, increase in net income, expanding profit margins and increase in stock price during the past year. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Las Vegas Sands Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the services sector could consider iShares Dow Jones US Cons Services ( IYC) while those bearish on the services sector could consider ProShares Ultra Short Consumer Sers ( SCC).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.
null

If you liked this article you might like

These Stocks Pay You to Own Them

FDA Official Calls for Ending Codeine Use in Kids Cough Products

Big Drug Makers Could Face More Pressure on Codeine Remedies for Kids

Cramer: Finding the Flaws in Amazon

Cardinal Health: Cramer's Top Takeaways